Retroviral vectors for expression in embryonic cells
OwnerDonald B. Kohn, Pia M. Challitainventors
Life of this patent
Estimating the term…
Abstract
Retroviral plasmid vectors which include an enhancer region obtained from a virus selected from the group consisting of Myeloproliferative Sarcoma Virus and polyoma virus, and a primer binding site obtained from murine retrovirus. The retroviral plasmid vector does not include a negative control region. The vector also may include a nucleic acid sequence which encodes demethylation of cytosine residues in the proviral LTR. Such plasmid vectors are especially useful in the generation of retroviral vector particles which may be expressed in embryonic cells, such as embryonic stem cells.
Claims12
A Maloney Murine Leukemia Virus vector comprising
- (i) a Maloney Murine Leukemia Virus LTR including an enhancer region wherein the enhancer region of the LTR has been removed and replaced with an enhancer region obtained from Myeloproliferative Sarcoma Virus;
- and wherein
- (ii) the Moloney Murine Leukemia Virus primer binding site is removed and replaced with a primer binding site obtained from murine retrovirus d1587rev, and wherein the Moloney Murine Leukemia Virus negative control region has been deleted.
A Moloney Murine Leukemia Virus vector comprising
- (i) a Moloney Murine Leukemia Virus LTR including an enhancer region wherein the enhancer region of the LTR has been removed and replaced with an enhancer region obtained from Myeloprolieferative Sarcoma Virus;
- and wherein
- (ii) the Moloney Murine leukemia Virus primer binding site is removed and replaced with a primer binding site obtained from murine retrovirus d1587rev;
- and wherein
- (iii) said vector includes a nucleic acid sequence which decreases methylation of said vector.
The vector of claim 4 wherein said vector further comprises at least one nucleic acid sequence encoding a protein.
Dependencies are inferred from the claim text.